<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>their mechanism (reward pathways) &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/their-mechanism-reward-pathways/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Mon, 26 Jan 2026 17:57:14 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=6.9.4</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>their mechanism (reward pathways) &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>Exploring GLP-1 Agonists’ Role in Alcohol Use Disorder</title>
		<link>https://bioengineer.org/exploring-glp-1-agonists-role-in-alcohol-use-disorder/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Mon, 26 Jan 2026 17:56:49 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[Alkol kullanım bozukluğu farmakoterapisi]]></category>
		<category><![CDATA[and the research context]]></category>
		<category><![CDATA[Bağımlılıkta ödül yolları]]></category>
		<category><![CDATA[Based on the content focusing on GLP-1 agonists' potential in treating alcohol use disorder]]></category>
		<category><![CDATA[GLP-1 agonistleri ve alkol bağımlılığı]]></category>
		<category><![CDATA[here are 5 appropriate tags: **GLP-1 agonists AUD]]></category>
		<category><![CDATA[Holistic recovery approaches** **Explanation:** 1. **GLP-1 agonists AUD:** Directly combines the key treatment (GLP-1 agonists) and the condition (Alcohol Use Disorder).]]></category>
		<category><![CDATA[İlaçla alkol arzusu kontrolü]]></category>
		<category><![CDATA[Neurobiological addiction treatment]]></category>
		<category><![CDATA[Nörobiyolojik tedaviler]]></category>
		<category><![CDATA[Pharmacotherapy advancements]]></category>
		<category><![CDATA[Reward pathway modulation]]></category>
		<category><![CDATA[their mechanism (reward pathways)]]></category>
		<guid isPermaLink="false">https://bioengineer.org/exploring-glp-1-agonists-role-in-alcohol-use-disorder/</guid>

					<description><![CDATA[Recent advancements in the field of addiction medicine have positioned GLP-1 receptor agonists as a promising therapeutic option for individuals grappling with alcohol use disorder (AUD). The significance of this discovery lies not merely in the potential to mitigate the physical cravings associated with alcohol dependency but also in its broader implications for treatment outcomes [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">321207</post-id>	</item>
	</channel>
</rss>
